Clinical use of erythromycin in children with gastrointestinal dysmotility.

Simple item page
dc.contributor.authorAanpreung, Pen_US
dc.contributor.authorVajaradul, Cen_US
dc.date.accessioned2009-05-27T19:07:28Z
dc.date.available2009-05-27T19:07:28Z
dc.date.issued2001-07-05en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractIntolerant feeding is a common symptom in gastrointestinal disorders which is commonly found in systemic diseases. Prokinetic drugs play a role in management. A low dose of erythromycin has an effect on improvement of antroduodenal motility and gastric emptying in children and adults. The objective of this study was to evaluate the efficacy of intravenous erythromycin in the treatment of GI dysmotility in children. Retrospective studies were performed in the Department of Pediatrics, Siriraj Hospital, Mahidol University between 1996 and 2000 in 22 patients with intolerance of feeding due to GI dysmotility. Their ages ranged from 11 days to 12 years (42.1 +/- 48.1 months). The patients were divided into 2 groups: 12 critically ill and 10 non-critically ill patients. Dosages of intravenous erythromycin were 1-3 mg/kg/dose every 6 hours. The result of treatment was evaluated as: good (tolerant feeding), fair (tolerant feeding but needing erythromycin for longer than 1 month) and failed (intolerant feeding). All non-critically ill patients had improved symptoms with 9 +/- 4.3 days duration of treatment. In the other group, 8 patients had good results with 10.9 +/- 6 days of treatment. Two patients needed the drug for longer than 1 month and the other 2 patients did not respond and died due to severe infection. Low dose intravenous erythromycin had good efficacy in the treatment of intolerant feeding related to GI dysmotility in children.en_US
dc.description.affiliationDepartment of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.en_US
dc.identifier.citationAanpreung P, Vajaradul C. Clinical use of erythromycin in children with gastrointestinal dysmotility. Journal of the Medical Association of Thailand. 2001 Jul; 84(7): 1021-6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/40515
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshErythromycin --administration & dosageen_US
dc.subject.meshFemaleen_US
dc.subject.meshGastric Emptying --drug effectsen_US
dc.subject.meshGastrointestinal Agents --administration & dosageen_US
dc.subject.meshGastrointestinal Motility --drug effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshInjections, Intravenousen_US
dc.subject.meshMaleen_US
dc.subject.meshRetrospective Studiesen_US
dc.titleClinical use of erythromycin in children with gastrointestinal dysmotility.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Medical Association of Thailand